top of page

Can Alzheimer’s Be Reversed? New NAD+ Research Suggests It May Be Possible

A New Study Says the Brain May Have More Repair Power Than We Thought

For more than a century, Alzheimer’s disease has been treated as a one-way road.

Once decline begins, the goal has been to slow it.Manage it.Delay it.


But never reverse it.


Now, a new study published in Cell Reports Medicine from researchers at University Hospitals Cleveland Medical Center, Case Western Reserve University, and the Louis Stokes Cleveland VA Medical Center is challenging that belief.

And the reason centers around something surprisingly fundamental:

Brain energy.


What Is NAD+ and Why Is It Critical for Brain Health?

At the center of this breakthrough is a molecule called NAD+ (nicotinamide adenine dinucleotide).


NAD+ is essential for:

  • Cellular energy production

  • DNA repair

  • Mitochondrial function

  • Cell survival


It naturally declines with age.But researchers found something more dramatic:

In both human Alzheimer’s brains and in Alzheimer’s mouse models, NAD+ levels dropped severely.


Not gradually.Not subtly.


But enough to impair the brain’s ability to maintain basic cellular function.

When brain cells lose energy balance, they struggle to:

  • Repair damage

  • Maintain synapses

  • Control inflammation

  • Support neurogenesis


And that’s when pathology accelerates.


What the Researchers Did

The team tested a powerful question:

What if we restore NAD+ balance after Alzheimer’s is already advanced?

They used two different mouse models:

  • One driven by amyloid mutations

  • One driven by tau mutations


Both developed:

  • Blood–brain barrier breakdown

  • Axonal degeneration

  • Neuroinflammation

  • Reduced hippocampal neurogenesis

  • Severe cognitive impairment


In other words — advanced Alzheimer’s-like pathology.


The Intervention: P7C3-A20

Instead of using over-the-counter NAD+ boosters (which can dangerously raise NAD+ levels systemically), researchers used a pharmacologic compound called P7C3-A20.


This drug:

  • Does not flood the body with NAD+

  • Helps cells maintain proper balance

  • Protects against NAD+ collapse under stress


And what happened next was remarkable.


The Results

In mice treated early:

  • Alzheimer’s pathology was prevented.


In mice treated after advanced disease had developed:

  • Brain structure repaired

  • Neuroinflammation reduced

  • Synaptic function restored

  • Cognitive function fully recovered


Not improved.

Recovered.


Blood levels of phosphorylated tau 217 — a clinical biomarker of Alzheimer’s in humans — normalized as well.


Why This Matters for Neuroplasticity

Alzheimer’s has long been framed as a structural disease:

  • Amyloid plaques

  • Tau tangles

  • Neuronal loss


But this study reframes it as, at least in part, a brain energy failure.

Neuroplasticity requires energy.


To:

  • Form new synapses

  • Repair damaged pathways

  • Generate new neurons

  • Strengthen existing networks


Without sufficient NAD+, those processes stall.

What this research suggests is profound:


If you restore energy balance, you may restore the brain’s ability to rewire itself.

That’s neuroplasticity reactivated.


Important Clarification

This research was conducted in animal models — not humans.


And researchers were clear:

  • Over-the-counter NAD+ supplements are not equivalent

  • Raising NAD+ indiscriminately may carry risks

  • This specific pharmacologic approach maintains balance rather than overloading the system


Human trials have not yet begun — but they are the next step.


A Paradigm Shift

For decades, Alzheimer’s research has aimed to:

  • Slow progression

  • Reduce symptoms

  • Delay decline


This study asks a different question:

What if the brain can repair itself under the right conditions?

According to senior author Andrew Pieper, MD, PhD:

“The key takeaway is a message of hope – the effects of Alzheimer’s disease may not be inevitably permanent. The damaged brain can, under some conditions, repair itself and regain function.”

That’s not just a treatment shift.

It’s a psychological shift.



Why This Matters Now

At the Rewiring Hope: The Neuroplasticity Summit (March 16–19, 2026), we are exploring one core idea:


The brain is more adaptable than we were taught.

This study reinforces that principle at the highest level of neurodegenerative disease research.


It shows:

  • Brain damage is not always final

  • Energy metabolism is central to recovery

  • Neuroplasticity depends on biological conditions

  • Recovery science is evolving


Hope in neuroscience is no longer abstract.It’s measurable.


The Bigger Question

If restoring energy balance can reopen plasticity in advanced Alzheimer’s…


What other conditions might respond to the same principle?

  • Traumatic brain injury

  • Parkinson’s

  • Mood disorders

  • Age-related cognitive decline


We are entering an era where the brain is not simply protected.

It is potentially reawakened.


Join Us

Rewiring Hope: The Neuroplasticity Summit 2026


This breakthrough in Alzheimer’s research aligns with the core theme of the Rewiring Hope:


The Neuroplasticity Summit (March 16–19, 2026) — exploring how the brain can repair, rewire, and recover under the right biological conditions.


At this year’s summit, experts will discuss:

  • The role of NAD+ in brain energy metabolism

  • Neuroplasticity and age-related cognitive decline

  • Emerging therapies targeting brain recovery

  • The science of reversing neurodegeneration


If restoring brain energy can reopen plasticity pathways, the conversation about Alzheimer’s is no longer just about slowing decline — it’s about the potential for recovery.


🔗 Join us March 16–19, 2026.





Comments


  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

 Atlanta, GA 30342  |  404.441.8329

©2026 by The Neuroplasticity Alliance. 

bottom of page